CUAMC
RLAY icon

China Universal Asset Management Company’s Relay Therapeutics RLAY Stock Holding History

China Universal Asset Management Company’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$639K Buy
34,138
+2,422
+8% +$35.2K 0.04% 243
2026
Q1 		$316K Buy
31,716
+3,473
+12% +$31.1K 0.02% 308
2025
Q4 		$239K Sell
28,243
-1,978
-7% -$14.1K 0.02% 332
2025
Q3 		$158K Sell
30,221
-4,213
-12% -$16.1K 0.01% 348
2025
Q2 		$119K Buy
34,434
+431
+1% +$1.28K 0.01% 349
2025
Q1 		$89.1K Sell
34,003
-1,488
-4% -$5.83K 0.01% 364
2024
Q4 		$146K Buy
35,491
+9,740
+38% +$53K 0.01% 355
2024
Q3 		$182K Buy
25,751
+10,157
+65% +$75.9K 0.02% 310
2024
Q2 		$102K Sell
15,594
-9,616
-38% -$65.7K 0.01% 301
2024
Q1 		$209K Buy
25,210
+10,953
+77% +$107K 0.03% 283
2023
Q4 		$157K Buy
14,257
+11,122
+355% +$93.9K 0.03% 229
2023
Q3 		$26.4K Buy
3,135
+1,541
+97% +$16.6K 0.01% 281
2023
Q2 		$20K Sell
1,594
-50
-3% -$622 0.01% 268
2023
Q1 		$27.1K Buy
1,644
+416
+34% +$7.46K 0.01% 192
2022
Q4 		$18.3K Buy
1,228
+208
+20% +$3.98K 0.01% 181
2022
Q3 		$23K Buy
+1,020
New +$22.4K 0.01% 148

Other funds holding RLAY

SB Investment Advisers (UK)
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Perceptive Advisors
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

China Universal Asset Management Company's RLAY Position: Q2 2026 in Review

China Universal Asset Management Company increased its Relay Therapeutics (RLAY) stake by 7.6% in Q2 2026, buying an estimated $35.2K and bringing the position to 34,138 shares worth $639K. The position accounts for 0.04% of the portfolio, ranked #243.

China Universal Asset Management Company first reported a position in RLAY in Q3 2022 and has held it in 16 quarters since. 259 funds tracked by Wall St. Rank hold RLAY as of Q2 2026.

  • China Universal Asset Management Company held 34,138 shares of Relay Therapeutics worth $639K as of Q2 2026.
  • China Universal Asset Management Company bought 2,422 Relay Therapeutics shares in Q2 2026, an estimated $35.2K.
  • Relay Therapeutics made up 0.04% of China Universal Asset Management Company's portfolio in Q2 2026, its #243 holding.
  • China Universal Asset Management Company first reported a position in Relay Therapeutics in Q3 2022 and has held it in 16 quarters since.
  • 259 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.